SPIN Self-Management Feasibility Trial With Progression to Full-scale Trial (SPIN-SELF)

Launched by LADY DAVIS INSTITUTE · Jan 28, 2020

Keywords

ClinConnect Summary

The SPIN Self-Management Feasibility Trial, also known as SPIN-SELF, is designed to help people living with scleroderma (systemic sclerosis) learn how to manage their condition better. This program was created by a group of researchers and healthcare providers, along with patients, to address the everyday challenges faced by those with scleroderma. The SPIN-SELF Program includes online resources and support through group sessions led by trained peers. Participants will have access to modules that focus on various issues, such as pain management, skin care, sleep problems, and emotional well-being, all tailored to help them improve their quality of life.

To be eligible for this trial, participants must be at least 18 years old, diagnosed with scleroderma, and experiencing difficulties managing their condition. They should also be fluent in English, French, or Spanish. The study is currently recruiting and will begin with a small group of 40 participants to test the program's feasibility before expanding to a larger group in the full-scale trial, which will include 524 participants. If you join the study, you can expect to engage with helpful online content and participate in supportive group discussions, all aimed at boosting your confidence in managing scleroderma.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • SPIN Cohort patients must have a systemic sclerosis (SSc) diagnosis based on 2013 American College of Rheumatology/European League Against Rheumatism criteria confirmed by a SPIN physician, be ≥18 years old, be able to give informed consent, and be fluent in English, French or Spanish.
• • For the feasibility trial, eligible patients must be able to use the online intervention in English, and have low disease management self-efficacy (Self-Efficacy for Managing Chronic Disease (SEMCD) ≤ 7).
• • For the full-scale trial, eligible patients must be able to use the online intervention in English or French, and have low disease management self-efficacy (Self-Efficacy for Managing Chronic Disease (SEMCD) ≤ 7).
• Exclusion Criteria:
• • Patients not able to access or respond to questionnaires via the internet are excluded.
• • Participants who are currently participating in another SPIN intervention trial and have not yet completed their final assessment measures will be excluded.
• • French and Spanish speaking participants will be excluded from the feasibility trial.
• • Spanish speaking participants will be excluded from the full-scale trial.
• • Participants in the feasibility trial will be excluded in the full-scale trial.